Controversies in the Treatment of Early Stage Endometrial Carcinoma

por Press, Joshua Z., Gotlieb, Walter H.
Publicado 2012

Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer

por Beauchamp, Marie-Claude, Yasmeen, Amber, Knafo, Ariane, Gotlieb, Walter H.
Publicado 2010

Expression patterns of maspin and mutant p53 are associated with the development of gestational trophoblastic neoplasia

por Sun, Pengming, Wu, Qibin, Ruan, Guanyu, Zheng, Xiu, Song, Yiyi, Zhun, Jianfan, Wu, Lixiang, Gotlieb, Walter H.
Publicado 2016

Sequential therapeutic targeting of ovarian Cancer harboring dysfunctional BRCA1

por Baloch, Tahira, López-Ozuna, Vanessa M., Wang, Qiong, Matanis, Emad, Kessous, Roy, Kogan, Liron, Yasmeen, Amber, Gotlieb, Walter H.
Publicado 2019

Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient

por Zhang, Jian, Shi, Yuhao, Lalonde, Emilie, Li, Lili, Cavallone, Luca, Ferenczy, Alex, Gotlieb, Walter H, Foulkes, William D, Majewski, Jacek
Publicado 2013

Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitors

por Amin, Oreekha, Beauchamp, Marie-Claude, Nader, Paul Abou, Laskov, Ido, Iqbal, Sanaa, Philip, Charles-André, Yasmeen, Amber, Gotlieb, Walter H.
Publicado 2015

Feasibility of a Pilot Randomized Controlled Trial Examining a Multidimensional Intervention in Women with Gynecological Cancer at Risk of Lymphedema

por Shallwani, Shirin M., Towers, Anna, Newman, Anne, Salvador, Shannon, Yung, Angela, Gilbert, Lucy, Gotlieb, Walter H., Zeng, Xing, Thomas, Doneal
Publicado 2021

Scalp cooling for reducing alopecia in gynecology oncology patients treated with dose-dense chemotherapy: A pilot project

por Mitric, Cristina, How, Brian, Matanes, Emad, Amajoud, Zainab, Zaaroura, Hiba, Nguyen, Hai-Hac, Tatar, Angela, Salvador, Shannon, Gotlieb, Walter H., Lau, Susie
Publicado 2021

Chemotherapy reduces PARP1 in cancers of the ovary: implications for future clinical trials involving PARP inhibitors

por Marques, Maud, Beauchamp, Marie-Claude, Fleury, Hubert, Laskov, Ido, Qiang, Sun, Pelmus, Manuela, Provencher, Diane, Mes-Masson, Anne-Marie, Gotlieb, Walter H., Witcher, Michael
Publicado 2015

Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors

por Philip, Charles-André, Laskov, Ido, Beauchamp, Marie-Claude, Marques, Maud, Amin, Oreekha, Bitharas, Joanna, Kessous, Roy, Kogan, Liron, Baloch, Tahira, Gotlieb, Walter H., Yasmeen, Amber
Publicado 2017

Impact of lower uterine segment involvement in type II endometrial cancer and the unique mutational profile of serous tumors

por Kogan, Liron, Octeau, David, Amajoud, Zainab, Abitbol, Jeremie, Laskov, Ido, Ferenczy, Alex, Pelmus, Manuela, Eisenberg, Neta, Kessous, Roy, Lau, Susie, Yasmeen, Amber, Gotlieb, Walter H., Salvador, Shannon
Publicado 2018

Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer

por López-Ozuna, Vanessa M., Kogan, Liron, Hachim, Mahmood Y., Matanes, Emad, Hachim, Ibrahim Y., Mitric, Cristina, Kiow, Lauren Liu Chen, Lau, Susie, Salvador, Shannon, Yasmeen, Amber, Gotlieb, Walter H.
Publicado 2021

Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum Agents

por Matanes, Emad, López-Ozuna, Vanessa M., Octeau, David, Baloch, Tahira, Racovitan, Florentin, Dhillon, Amandeep Kaur, Kessous, Roy, Raban, Oded, Kogan, Liron, Salvador, Shannon, Lau, Susie, Gotlieb, Walter H., Yasmeen, Amber
Publicado 2021

Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsy

por Octeau, David, Abitbol, Jeremie, Amajoud, Zainab, Laskov, Ido, Ferenczy, Alex, Pelmus, Manuela, Eisenberg, Neta, Kessous, Roy, Matanes, Emad, Lau, Susie, Yasmeen, Amber, Lopez-Ozuna, Vanessa, Salvador, Shannon, Gotlieb, Walter H., Kogan, Liron
Publicado 2019

Multi-omics data integration analysis identifies the spliceosome as a key regulator of DNA double-strand break repair

por Sherill-Rofe, Dana, Raban, Oded, Findlay, Steven, Rahat, Dolev, Unterman, Irene, Samiei, Arash, Yasmeen, Amber, Kaiser, Zafir, Kuasne, Hellen, Park, Morag, Foulkes, William D, Bloch, Idit, Zick, Aviad, Gotlieb, Walter H, Tabach, Yuval, Orthwein, Alexandre
Publicado 2022

GD2 and GD3 gangliosides as diagnostic biomarkers for all stages and subtypes of epithelial ovarian cancer

por Galan, Alba, Papaluca, Arturo, Nejatie, Ali, Matanes, Emad, Brahimi, Fouad, Tong, Wenyong, Hachim, Ibrahim Yaseen, Yasmeen, Amber, Carmona, Euridice, Klein, Kathleen Oros, Billes, Sonja, Dawod, Ahmed E., Gawande, Prasad, Jeter, Anna Milik, Mes-Masson, Anne-Marie, Greenwood, Celia M. T., Gotlieb, Walter H., Saragovi, H. Uri
Publicado 2023

Investigating the causal role of MRE11A p.E506* in breast and ovarian cancer

por Elkholi, Islam E., Di Iorio, Massimo, Fahiminiya, Somayyeh, Arcand, Suzanna L., Han, HyeRim, Nogué, Clara, Behl, Supriya, Hamel, Nancy, Giroux, Sylvie, de Ladurantaye, Manon, Aleynikova, Olga, Gotlieb, Walter H., Côté, Jean-François, Rousseau, François, Tonin, Patricia N., Provencher, Diane, MesMasson, Anne-Marie, Akbari, Mohammad R., Rivera, Barbara, Foulkes, William D.
Publicado 2021

Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers

por Le Page, Cécile, Rahimi, Kurosh, Köbel, Martin, Tonin, Patricia N., Meunier, Liliane, Portelance, Lise, Bernard, Monique, Nelson, Brad H., Bernardini, Marcus Q., Bartlett, John M. S., Bachvarov, Dimcho, Gotlieb, Walter H., Gilks, Blake, McAlpine, Jessica N., Nachtigal, Mark W., Piché, Alain, Watson, Peter H., Vanderhyden, Barbara, Huntsman, David G., Provencher, Diane M., Mes-Masson, Anne-Marie
Publicado 2018

Author Correction: SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria

por Xue, Yibo, Morris, Jordan L., Yang, Kangning, Fu, Zheng, Zhu, Xianbing, Johnson, Fraser, Meehan, Brian, Witkowski, Leora, Yasmeen, Amber, Golenar, Tunde, Coatham, Mackenzie, Morin, Geneviève, Monast, Anie, Pilon, Virginie, Fiset, Pierre Olivier, Jung, Sungmi, Gonzalez, Anne V., Camilleri-Broet, Sophie, Fu, Lili, Postovit, Lynne-Marie, Spicer, Jonathan, Gotlieb, Walter H., Guiot, Marie-Christine, Rak, Janusz, Park, Morag, Lockwood, William, Foulkes, William D., Prudent, Julien, Huang, Sidong
Publicado 2023

SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca(2+) flux to mitochondria

por Xue, Yibo, Morris, Jordan L., Yang, Kangning, Fu, Zheng, Zhu, Xianbing, Johnson, Fraser, Meehan, Brian, Witkowski, Leora, Yasmeen, Amber, Golenar, Tunde, Coatham, Mackenzie, Morin, Geneviève, Monast, Anie, Pilon, Virginie, Fiset, Pierre Olivier, Jung, Sungmi, Gonzalez, Anne V., Camilleri-Broet, Sophie, Fu, Lili, Postovit, Lynne-Marie, Spicer, Jonathan, Gotlieb, Walter H., Guiot, Marie-Christine, Rak, Janusz, Park, Morag, Lockwood, William, Foulkes, William D., Prudent, Julien, Huang, Sidong
Publicado 2021